| FNARX | RYVAX | FNARX / RYVAX | |
| Total Expense Ratio | 0.69 | 1.63 | 42% |
| Annual Report Gross Expense Ratio | 0.69 | 1.68 | 41% |
| Fund Existence | 29 years | 28 years | - |
| Gain YTD | 21.017 | 48.656 | 43% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 984M | 50.6M | 1,945% |
| Annual Yield % from dividends | 1.79 | 0.41 | 439% |
| Returns for 1 year | 35.70 | 73.90 | 48% |
| Returns for 3 years | 73.63 | 61.14 | 120% |
| Returns for 5 years | 156.83 | 76.34 | 205% |
| Returns for 10 years | 162.29 | -25.67 | -632% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| USLUX | 21.50 | 0.03 | +0.14% |
| US Global Investors Global Luxury Goods | |||
| ICEWX | 54.29 | 0.01 | +0.02% |
| NYLI Epoch International Choice Class C | |||
| CWVGX | 27.01 | N/A | N/A |
| Calvert International Equity A | |||
| CDOYX | 47.58 | N/A | N/A |
| Columbia Dividend Opportunity Inst3 | |||
| VSCAX | 32.81 | -0.51 | -1.53% |
| Invesco Small Cap Value A | |||